T0	KEYPHRASE-NOTYPES 0 46	Bacterial meningitis clinical prediction rules
T1	KEYPHRASE-NOTYPES 56 64	children
T2	KEYPHRASE-NOTYPES 70 89	cerebrospinal fluid
T3	KEYPHRASE-NOTYPES 91 94	CSF
T4	KEYPHRASE-NOTYPES 96 107	pleocytosis
T5	KEYPHRASE-NOTYPES 124 132	low risk
T6	KEYPHRASE-NOTYPES 136 156	bacterial meningitis
T7	KEYPHRASE-NOTYPES 176 202	Lyme disease endemic areas
T8	KEYPHRASE-NOTYPES 233 252	mid-Atlantic states
T9	KEYPHRASE-NOTYPES 254 262	children
T10	KEYPHRASE-NOTYPES 268 283	CSF pleocytosis
T11	KEYPHRASE-NOTYPES 295 303	low risk
T12	KEYPHRASE-NOTYPES 307 327	bacterial meningitis
T13	KEYPHRASE-NOTYPES 343 358	Lyme meningitis
T14	KEYPHRASE-NOTYPES 389 394	weeks
T15	KEYPHRASE-NOTYPES 398 420	parenteral antibiotics
T16	KEYPHRASE-NOTYPES 445 457	several days
T17	KEYPHRASE-NOTYPES 489 505	serology results
T18	KEYPHRASE-NOTYPES 507 517	clinicians
T19	KEYPHRASE-NOTYPES 566 587	empirical antibiotics
T20	KEYPHRASE-NOTYPES 592 600	children
T21	KEYPHRASE-NOTYPES 621 636	Lyme meningitis
